Method for making pharmaceutical multiparticulates

Details for Australian Patent Application No. 2004294817 (hide)

Owner Pfizer Products Inc.

Inventors Crew, Marshall David; Ray, Roderick Jack; Friesen, Dwayne Thomas; Appel, Leah Elizabeth

Agent Shelston IP

Pub. Number AU-B-2004294817

PCT Pub. Number WO2005/053655

Priority 60/527,316 04.12.03 US

Filing date 24 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 25 January 2007

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/7052 (2006.01)

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/053655 Priority application(s): WO2005/053655

25 January 2007 Application Accepted

  Published as AU-B-2004294817

24 May 2007 Standard Patent Sealed

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294818-Azithromycin multiparticulate dosage forms by liquid-based processes

2004294813-Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride